Therapeutics | Yale Ventures

Therapeutics

Arya

Generation of a humanized antibody with a proven effect for the prevention of Thoracic and abdominal Aortic aneurysm Dissection in mice

MARTIN

Therapeutic targeting of protocadherin gamma A9 (Pcdhga9)

Evershield: Long-acting, biodegradable implants for local, sustained drug release

Ranjit

B3 Therapeutics: Bypassing the blood brain barrier for the treatment of primary CNS tumors and brain metastases

Seth Herzon

DNA Self-Activating Warheads (SAWs)

Jose

Targeting Non-Tuberculous Mycobacteria with AI-Designed Antimicrobial Peptides

Ho-Joon

EDDIT: Early Drug Discovery for Targeted Protein Degradation

Waxman

ChondroNEXT will prevent progression of Osteoarthritis by preventing joint degeneration.

Bunick Head Shot

Novel treatment for hypertrophic and keloidal scarring

Markus

A new class of selective GSK3B-inhibitors for refractory lymphoid malignancies

Subscribe to Therapeutics